Neogen Corporation
General ticker "NEOG" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $1.6B (TTM average)
Neogen Corporation follows the US Stock Market performance with the rate: 48.7%.
Estimated limits based on current volatility of 2.0%: low 11.45$, high 11.85$
Factors to consider:
- Total employees count: 2974 (+2.0%) as of 2025
- US accounted for 50.3% of revenue in the fiscal year ended 2024-05-31
- Top business risk factors: Integration of 3M food safety, Geopolitical risks, Pandemic risks, Market competition, Economic downturns and volatility
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-05-31 to 2028-05-30
- 2026-05-31 to 2027-05-31 estimated range: [6.76$, 12.97$]
- 2027-05-31 to 2028-05-30 estimated range: [6.51$, 12.44$]
Financial Metrics affecting the NEOG estimates:
- Positive: with PPE of 28.4 at the end of fiscal year the price was low
- Positive: -4.23 < Operating profit margin, % of -2.42
- Positive: 42.26 < Shareholder equity ratio, % of 62.55 <= 63.63
- Positive: -3.10 < Return on assets ratio (scaled to [-100,100]) of -0.24
- Positive: Interest expense per share per price, % of 2.91 <= 3.34
- Positive: Investing cash flow per share per price, % of 3.56 > -0.64
- Positive: Inventory ratio change, % of -3.24 <= -0.75
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of 0.06 <= 0.27
Short-term NEOG quotes
Long-term NEOG plot with estimates
Financial data
| YTD | 2024-05-31 | 2025-05-31 | 2026-05-31 |
|---|---|---|---|
| Operating Revenue | $924.22MM | $894.66MM | $870.40MM |
| Operating Expenses | $865.56MM | $1,955.66MM | $892.00MM |
| Operating Income | $58.66MM | $-1,061.00MM | $-21.60MM |
| Non-Operating Income | $-72.97MM | $-72.11MM | $12.60MM |
| Interest Expense | $73.39MM | $71.62MM | $57.60MM |
| R&D Expense | $22.48MM | $21.09MM | $18.40MM |
| Income(Loss) | $-14.30MM | $-1,133.11MM | $-9.00MM |
| Taxes | $-4.88MM | $-41.07MM | $-1.10MM |
| Net Income(Loss)* | $-9.42MM | $-1,092.04MM | $-7.90MM |
| Stockholders Equity | $3,144.14MM | $2,071.25MM | $2,092.90MM |
| Inventory | $189.27MM | $190.86MM | $144.30MM |
| Assets | $4,548.83MM | $3,443.84MM | $3,346.00MM |
| Operating Cash Flow | $35.26MM | $58.24MM | $83.20MM |
| Capital expenditure | $111.42MM | $104.59MM | $51.30MM |
| Investing Cash Flow | $-29.31MM | $-99.19MM | $70.50MM |
| Financing Cash Flow | $1.92MM | $-1.60MM | $-99.40MM |
| Earnings Per Share** | $-0.04 | $-5.03 | $-0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.